Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Docetaxel × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 29 Prostatic Neoplasms 19 Squamous Cell Carcinoma of Head and Neck 14 Breast Neoplasms 13 Lung Neoplasms 8 Stomach Neoplasms 6 Urinary Bladder Neoplasms 5 Neoplasm Metastasis 5 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms, Castration-Resistant 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Ovarian Neoplasms 4 Neoplasms 4 Carcinoma, Transitional Cell 4 Small Cell Lung Carcinoma 3 Sarcoma 3 Salivary Gland Neoplasms 3 Recurrence 3 Oropharyngeal Neoplasms 3 Nasopharyngeal Carcinoma 3 Laryngeal Neoplasms 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Squamous Cell 3 Advanced Solid Tumors 3 Adenocarcinoma Of Esophagus 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Solid Tumors 2

Interventions

X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 Magnetic Resonance Spectroscopy 3 Biopsy 3 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 ulixertinib 1 tipifarnib 1 temsirolimus 1 tazemetostat 1 talazoparib 1 selpercatinib 1 palbociclib 1 olaparib 1 larotrectinib 1 irinotecan sucrosofate 1 Vincristine 1 Vemurafenib 1 Surgical Procedures, Operative 1 Sorafenib 1 Radiation 1 Proton Therapy 1 Liquid Biopsy 1 LY3023414 1 Ifosfamide 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡